Kaufman D L, Clare-Salzler M, Tian J, Forsthuber T, Ting G S, Robinson P, Atkinson M A, Sercarz E E, Tobin A J, Lehmann P V
Department of Psychiatry and Biobehavioral Sciences, University of California at Los Angeles 90024.
Nature. 1993 Nov 4;366(6450):69-72. doi: 10.1038/366069a0.
Insulin-dependent diabetes mellitus (IDDM) in non-obese diabetic (NOD) mice results from the T-lymphocyte-mediated destruction of the insulin-producing pancreatic beta-cells and serves as a model for human IDDM. Whereas a number of autoantibodies are associated with IDDM, it is unclear when and to what beta-cell antigens pathogenic T cells become activated during the disease process. We report here that a T-helper-1 (Th1) response to glutamate decarboxylase develops in NOD mice at the same time as the onset of insulitis. This response is initially limited to a confined region of glutamate decarboxylase, but later spreads intramolecularly to additional determinants. Subsequently, T-cell reactivity arises to other beta-cell antigens, consistent with intermolecular diversification of the response. Prevention of the spontaneous anti-glutamate decarboxylase response, by tolerization of glutamate decarboxylase-reactive T cells, blocks the development of T-cell autoimmunity to other beta-cell antigens, as well as insulitis and diabetes. Our data suggest that (1) glutamate decarboxylase is a key target antigen in the induction of murine IDDM; (2) autoimmunity to glutamate decarboxylase triggers T-cell responses to other beta-cell antigens, and (3) spontaneous autoimmune disease can be prevented by tolerization to the initiating target antigen.
非肥胖型糖尿病(NOD)小鼠的胰岛素依赖型糖尿病(IDDM)是由T淋巴细胞介导的胰岛素生成胰腺β细胞破坏所致,可作为人类IDDM的模型。虽然多种自身抗体与IDDM相关,但尚不清楚在疾病过程中致病性T细胞何时以及针对何种β细胞抗原被激活。我们在此报告,在NOD小鼠中,对谷氨酸脱羧酶的辅助性T细胞1(Th1)反应与胰岛炎的发作同时出现。这种反应最初局限于谷氨酸脱羧酶的一个受限区域,但后来在分子内扩散到其他决定簇。随后,出现了针对其他β细胞抗原的T细胞反应性,这与反应的分子间多样化一致。通过使谷氨酸脱羧酶反应性T细胞耐受来预防自发的抗谷氨酸脱羧酶反应,可阻断对其他β细胞抗原的T细胞自身免疫的发展,以及胰岛炎和糖尿病的发展。我们的数据表明:(1)谷氨酸脱羧酶是诱导小鼠IDDM的关键靶抗原;(2)对谷氨酸脱羧酶的自身免疫引发了对其他β细胞抗原的T细胞反应;(3)通过对起始靶抗原的耐受可预防自发性自身免疫疾病。